-
Pfizer signs agreement with Gilead Sciences to manufacture remdesivir
expresspharma
August 10, 2020
Pfizer will provide contract manufacturing services through its McPherson, Kansas plant.
-
Pfizer and BioNTech to supply 120 million Covid-19 vaccine doses to Japan
pharmaceutical-technology
August 04, 2020
Pfizer and BioNTech have entered an agreement with Japan’s Ministry of Health, Labour and Welfare (MHLW) to provide 120 million doses of their BNT162 Covid-19 vaccine candidate.
-
PPD, Pfizer Ink New Service Pact
contractpharma
August 04, 2020
PPD to provide drug development services to advance Pfizer’s portfolio under new three-year agreement.
-
Pfizer, BioNTech Reach Deal with Japanese Government
contractpharma
August 04, 2020
Supply of 120 million vaccine doses to be provided in the first half of 2021, subject to regulatory approval.
-
Pfizer and BioNTech sign deal with Japan for 120 mn doses of mRNA-based COVID-19 vaccine
expresspharma
August 03, 2020
The companies have begun a Phase 2b/3 safety and efficacy trial and remain on track to seek regulatory review as early as October 2020.
-
Pfizer-BioNTech to commence late stage study of COVID-19 vaccine candidate
expresspharma
July 29, 2020
BioNTech and Pfizer informed they would begin the Phase2/3 trial to evaluate their COVID-19 vaccine candidate.
-
Pfizer and BioNTech select lead mRNA vaccine against COVID-19
pharmatimes
July 28, 2020
Pfizer and BioNTech have started a global Phase II/III safety and efficacy clinical study to evaluate a single nucleoside-modified messenger RNA (modRNA) candidate from their BNT162 mRNA-based vaccine programme against SARS-CoV-2.
-
US sets global benchmark for COVID-19 vaccine price at around the cost of a flu shot
expresspharma
July 27, 2020
Unlike other vaccine deals signed by the government, Pfizer and BioNTech will not collect a payment until their vaccine proves to be safe and effective in a large pivotal clinical trial expected to start this month.
-
US to pay Pfizer, BioNTech $1.95 billion for COVID-19 vaccine
expresspharma
July 24, 2020
The contract for 100 million doses of the vaccine amounts to a $39 price tag for what is likely to be a two-dose course of treatment.
-
U.S. Inks $2B COVID-19 Vax Deal with Pfizer, BioNTech
contractpharma
July 24, 2020
U.S. government placed an initial order of 100 million doses and can acquire up to 500 million additional doses.